CC BY-NC-ND 4.0 · Rev Bras Ortop (Sao Paulo) 2019; 54(04): 453-458
DOI: 10.1055/s-0039-1688755
Artigo Original | Original Article
Sociedade Brasileira de Ortopedia e Traumatologia. Published by Thieme Revnter Publicações Ltda Rio de Janeiro, Brazil

Results of Medium-Term Survival of the Non-Cemented Logical Femoral Stem[*]

Article in several languages: português | English
1   Programa de Pós-Graduação em Medicina, Ciências Cirúrgicas, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil
2   Serviço de Ortopedia e Traumatologia, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brasil
3   Departamento de Cirurgia, Faculdade de Medicina (FAMED), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil
,
Tiango Aguiar Ribeiro
1   Programa de Pós-Graduação em Medicina, Ciências Cirúrgicas, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil
4   Departamento de Cirurgia, Curso de Medicina, Universidade Federal de Santa Maria (UFSM), Santa Maria, RS, Brasil
5   Serviço de Ortopedia e Traumatologia, Hospital Universitário de Santa Maria (SOT-HUSM), Santa Maria, RS, Brasil
,
Carlos Alberto de Souza Macedo
2   Serviço de Ortopedia e Traumatologia, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brasil
3   Departamento de Cirurgia, Faculdade de Medicina (FAMED), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil
,
Carlos Roberto Galia
1   Programa de Pós-Graduação em Medicina, Ciências Cirúrgicas, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil
2   Serviço de Ortopedia e Traumatologia, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brasil
3   Departamento de Cirurgia, Faculdade de Medicina (FAMED), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brasil
› Author Affiliations
Further Information

Endereço para correspondência

Cristiano Valter Diesel, MD, MSc
Serviço de Ortopedia e Traumatologia do Hospital de Clínicas de Porto Alegre
Rua Ramiro Barcelos, 2350, Porto Alegre, Rio Grande do Sul, Brasil. CEP: 90035-903

Publication History

31 March 2018

10 July 2018

Publication Date:
20 August 2019 (online)

 

Abstract

Objective The main objective of the present study was to evaluate the clinical and radiographic results of the Logical (Baumer, Mogi Mirim, SP, Brasil) cementless femoral stem in primary total hip arthroplasties (THAs).

Methods A retrospective cohort study of 632 patients submitted to primary THA with the Logical cementless femoral stem. The study period was between January 2004 and January 2015. The outcome defined to evaluate the survival of the stem was the clinical and radiographic indication of the revision hip arthroplasty or the actual revision of the femoral stem for any cause.

Results Kaplan-Meier survival curves were estimated at > 95%, with a follow-up ranging from 2 to 13 years. There was a low incidence of transoperative periprosthetic fractures (0.02%). No axial migration or cortical bone atrophy was observed in the radiographic sample evaluated.

Conclusions In the intermediate follow-up, there was excellent survival of the Logical cementless femoral stem. Although long-term studies are still awaited, this implant appears to be safe and promising to be used for primary THAs.


#

Introduction

Cementless stems are widely used in total hip arthroplasty (THA). However, the term cementless is a generic description referring to a large group of implants without polymethylmethacrylate (PMNA) as an interface between the host bone and the prosthesis. Due to the lack of PMNA, the stem must be directly fixed to the bone, thus being more dependent on its shape, porosity, metal type, and design.

Since there is a great diversity in combining these characteristics, cementless implants have variable results. Several stem models showed excellent clinical and radiographic outcomes; others, however, did not perform well, and some had catastrophic results.[1] [2] [3]

In the 1990s, although the world experienced a boom in cementless stems, with easy access to these implants, the socioeconomic peculiarities of some countries made the access to high-quality cementless materials scarce and difficult. We believe this was true for Brazil.

In this scenario, the development of a cementless stem with quadrangular and double-wedge design, considered the most appropriate by the authors, was initiated. In addition, this cementless stem had to be submitted to all of the tests required by the Food and Drugs Administration (FDA) and by the American Society for Testing and Materials (ASTM) and, above all, it had to demonstrate a high-quality standard at the most rigorous laboratory tests.

The result was a cementless, quadrangular, double-wedge base core with flaps on the anterior and posterior surfaces and forged in a titanium, aluminum and vanadium alloy. The adopted cervical-diaphysis angle was 135°, with a Morse cone of 12/14 mm. The entire implant was covered by thick textured sandblasting, and its proximal third had a porous circumferential layer of pure, spray-deposited titanium. These implants were produced in sizes 8, 9, 10, 11.25, 12.5, 13.75 and 15. More robust stems, sizes 16, 18 and 20, have similar characteristics, but the titanium layer virtually covers the whole device[4] ([Fig. 1]).

Zoom Image
Fig. 1 Cementless femoral stem Logical – initial model.[4]

Although the first steps were successful and the basic metallurgical assumptions, rigorous biomechanical tests, finite element analysis, and laboratory control results validated the implant production and quality,[4] they do not attest nor guarantee its success in the clinical environment, that is, when subjected to all kinds of in vivo situations ([Fig. 2]).

Zoom Image
Fig. 2 Photographs of a Logical stem removed due to infection. The images show clear bone growth at the porous surface of the stem.

To evaluate the performance of the Logical (Baumer, Mogi Mirim, SP, Brasil) cementless stem, we have analyzed all cases of primary hip arthroplasty using this implant in our institution between 2004 and 2015. The study included 632 patients.


#

Material and Methods

Data from all of the patients submitted to THA with a Logical stem between 2004 and 2015 and followed-up in the Hip Surgery outpatient facility were collected from the electronic and physical file system. Although the database contained > 1,000 patients, those in which the stem was used in proximal femoral fractures, arthroplasty revision, and fractures resulting from bone metastases or primary bone tumors were excluded, leaving a total of 632 patients.

All of the surgeries were performed or supervised by four orthopedic surgeons specialized in hip surgery. The posterolateral approach was used in all of the cases. The antibiotic prophylaxis adopted was intravenous cefazolin administration according to the institutional protocol, whereas postoperative thromboprophylaxis was performed with subcutaneous enoxaparin. The patients returned for visits at the 15th, 45th, and 90th postoperative days; after this initial period, visits occurred every 6 months in the first 18 months, and then annually. Control radiographs were obtained in the immediate postoperative period, at 45 days and at 180 days postoperatively. Afterwards, radiographic examinations were performed annually.

The evaluated outcome was the need for femoral component revision due to radiographic signs of loosening or to pain associated with the surgery. For outcome purposes, the date of the surgical revision indication was considered the date of implant failure.

The following inclusion criteria were adopted: primary THA performed due to primary or secondary hip arthrosis with the Logical stem and compliance with the periodic follow-up in the orthopedic service. Patients who underwent partial or bipolar hip arthroplasty due to proximal femoral fracture, revisions of Logical arthroplasty, and those with pathological fractures of the proximal femur were excluded.

Epidemiological data were tabulated according to gender, age, and surgical indication. Data regarding the size of the used implants was also collected, in addition to infection, intraoperative femoral fracture and postoperative periprosthetic fracture rates.

Due to the large number of patients, a sample of 55 cases was randomly selected for radiographic analysis, which was performed by 2 different authors (Galia C. R. and Diesel C. V.), separately and at different times. The concordance between the evaluators was measured by the kappa index.

For the radiographic analysis, anterior-posterior hip radiographs were used and the axial migration of the stem, the presence of stress shielding, the appearance of radiolucent lines in the Gruen zones, and a pedestal formation at the stem tip were evaluated. Axial migration was considered present when the distance from the top of the greater trochanter and the shoulder of the stem was > 5 mm with an interval of 1 year from one radiograph to the other ([Fig. 3]).

Zoom Image
Fig. 3 Radiographical aspect of the Logical cementless stem – left hip arthroplasty performed in 2012.

Radiographic loosening was defined by axial migration > 5 mm, especially with progression over the years and associated with pedestal formation at the tip of the stem. The progressive formation of radiolucent lines > 2 mm in the Gruen areas was also used as a marker for implant loosening.

Survival curves were calculated by the Kaplan-Meier test and were expressed accordingly. The differences in survival between genders were evaluated by the Mantel-Cox test. Other numerical variables were presented in percentages.


#

Results

A total of 632 patients were included in the present study; all of them underwent a THA using the LOGICAL CM implant. Of these patients, 54.7% (346) were females and 45.3% (286) were males. The mean follow-up time was of 6.41 ± 3.1 years (mean ± standard deviation [SD]), ranging from 2 to 13 years.

For a better understanding of the analysis, the subjects were divided into 2 groups from different moments in time: patients operated from January 2004 to December 2009 (totaling 244 patients), and those operated from January 2010 to December 2015 (totaling 388 patients).

Of the patients operated from January 2004 to December 2009, the mean follow-up time was of 9.73 ± 1.42 years (mean ± SD), ranging from 8 to 13 years. Their survival curves are shown in [Figs. 4] [5] to [6].

Zoom Image
Fig. 4 LOGICAL CM implant survival in patients operated from January 2004 to December 2009. Over 95% of the implants had a mean survival of 12.72 ± 0.09 years (mean ± standard deviation) with a confidence interval of 12.57–12.87 years.
Zoom Image
Fig. 5 LOGICAL CM implant survival in patients operated from January 2004 to December 2009 evaluating differences between genders. There was no difference in the mean implant survival comparing males and females. The Log Ranl test (Mantel-Cox) was used (p = 0.878). The mean survival was 12.74 ± 0.10 years for females and 12.73 ± 0.13 years for males.
Zoom Image
Fig. 6 The cumulative risk of failure of the LOGICAL CM implant in patients operated from January 2004 to December 2009 over 12.5 years was 10.7%.

Of the patients operated from January 2010 to December 2015, the mean follow-up time was of 4.32 ± 1.74 years (mean ± SD), ranging from 2 to 8 years. Their survival curves are shown in [Figs. 7] [8] to [9].

Zoom Image
Fig. 7 LOGICAL CM implant survival in patients operated from January 2010 to December 2015. Over 98% of the implants had a mean survival of 7.89 ± 0.04 years (mean ± standard deviation), with a confidence interval of 7.81–7.98 years.
Zoom Image
Fig. 8 LOGICAL CM implant survival of patients operated from January 2010 to December 2015 evaluating differences between genders. There was no difference in the mean implant survival comparing males and females. The Log Ranl test (Mantel-Cox) (p = 0.287) was used. The mean survival was 7.94 ± 0.04 years for females and 7.85 ± 0.06 years for males.
Zoom Image
Fig. 9 The cumulative risk of failure of the LOGICAL CM implant in patients operated from January 2010 to December 2015 over 8 years was 6.51%.

The main sizes of the femoral components used are shown in [Fig. 10].

Zoom Image
Fig. 10 Femoral components sizes.

No surgical revision was performed due to residual thigh pain or to axial stem migration > 5 mm. In the studied period, 14 transoperative periprosthetic fractures (0.02%) were observed, and most of them were treated by cerclage with metallic wires.

There were no cases of bone atrophy (stress shielding) in the radiographic sample analyzed.


#

Discussion

Belief guides many steps in the evolution of knowledge. The fusion of belief and physical, mechanical, and biological principles in orthopedics can result in solutions, as successful or unsuccessful products. Institutionally, there was the belief that the most suitable design for a cementless femoral stem would be quadrangular and cuneiform. This belief was supported by the mechanical and biological pillars already studied by several authors and with proven success over the years, such as the CLS (Zimmer. Warsaw, Indiana, USA) femoral stems.[5] [6] [7] This led to the development of a cementless, quadrangular, cuneiform stem with pores and proximal flaps.

The Logical stem was used in the most diverse situations and indications, such as THA, partial arthroplasty for the treatment of proximal femoral fractures, metastatic lesions of the proximal femoral third, and revisions of the femoral component. Since 2004, more than 1,000 femoral stems have been implanted in our institution.

The early years were dedicated to instrumental adjustments and improvements, in addition to the observation of the postoperative evolution of the patients. These were also the years for the learning curve of the implant.

The evolution of the first cases was encouraging, allowing a greater liberty in indicating this cementless stem. Age group, Dorr concepts, and morphocortical indexes gradually ceased to be criteria to indicate this device.

We did not observe axial migration of the femoral stem in the evaluated radiographic sample. Although not all of the radiographs were analyzed, the design of the implant and its adaptation to the femoral canal, in addition to the low number of revision indications, lead us to believe that this event is rare

A total of 14 transoperative periprosthetic fractures (0.02%) were observed. Although the values found in the literature are variable (ranging from 0.1% to 27.8%),[8] we attribute this low number of cases to the institutional experience with this cementless stem – the only one used at our facility since 2004.

As expected, we also did not find evidence of cortical bone atrophy (stress shielding) in the radiographic sample analyzed. We attribute this fact to the features of the cementless implant (double-wedged, with proximal porosity and biocompatible). These features, among others, increase the load distribution at the bone-implant interface and reduce the incidence of bone atrophy.

Although a medium-term follow-up is still insufficient in terms of orthopedic implants, the results obtained and expressed in the survival curves are very encouraging.

Currently, ceramic heads are adapted to the Logical stem and their acetabular assembly presents crosslinked polyethylene. Over time, we expect a greater number of revision indications in the analyzed cases, since the tribological pair used in most of them is composed of ultra-high molecular weight polyethylene and metal. Aspects related to particles generation and their repercussion in THA survival are well-known. Therefore, we believe that the following years will be very challenging.


#
#

Declaração de Conflito de Interesses

Um dos autores, Dr. Macedo C. A. S., declara haver conflito de interesses, visto ser o responsável pelo desenvolvimento da haste femoral Logical e ter cedido a tecnologia à empresa Baumer, Mogi Mirim, SP, Brasil.

* Work performed at the Hospital de Clínicas de Porto Alegre (HCPA); Serviço de Ortopedia e Traumatologia; Ambulatório de Cirurgia do Quadril, Porto Alegre, Rio Grande do Sul, Brazil.


  • Referências

  • 1 Aldinger PR, Jung AW, Breusch SJ, Ewerbeck V, Parsch D. Survival of the cementless Spotorno stem in the second decade. Clin Orthop Relat Res 2009; 467 (09) 2297-2304
  • 2 Johanson PE, Antonsson M, Shareghi B, Kärrholm J. Early Subsidence Predicts Failure of a cemented femoral stem with minor design changes. Clin Orthop Relat Res 2016; 474 (10) 2221-2229
  • 3 Kitamura S, Hasegawa Y, Iwasada S, Yamauchi K, Kawamoto K, Kanamono T. , et al. Catastrophic failure of cementless total hip arthroplasty using a femoral component without surface coating. J Arthroplasty 1999; 14 (08) 918-924
  • 4 Macedo CAS. Desenvolvimento de haste femoral não cimentada nacional, validada por normas internacionais [tese]. Porto Alegre: Universidade Federal do Rio Grande do Sul; 2007
  • 5 Rozkydal Z, Janícek P, Havlícek V, Pazourek L. [Long-term results of use of the CLS stem in primary total hip arthroplasty]. Acta Chir Orthop Traumatol Cech 2009; 76 (04) 281-287
  • 6 Evola FR, Evola G, Graceffa A, Sessa A, Pavone V, Costarella L. , et al. Performance of the CLS Spotorno uncemented stem in the third decade after implantation. Bone Joint J 2014; 96-B (04) 455-461
  • 7 Yamasaki T, Yasunaga Y, Mori R, Hamanishi M, Shoji T, Ochi M. The Cementless Spotorno stem in THA: 10 year results. Hip Int 2014; 24 (01) 98-102
  • 8 Sidler-Maier CC, Waddell JP. Incidence and predisposing factors of periprosthetic proximal femoral fractures: a literature review. Int Orthop 2015; 39 (09) 1673-1682

Endereço para correspondência

Cristiano Valter Diesel, MD, MSc
Serviço de Ortopedia e Traumatologia do Hospital de Clínicas de Porto Alegre
Rua Ramiro Barcelos, 2350, Porto Alegre, Rio Grande do Sul, Brasil. CEP: 90035-903

  • Referências

  • 1 Aldinger PR, Jung AW, Breusch SJ, Ewerbeck V, Parsch D. Survival of the cementless Spotorno stem in the second decade. Clin Orthop Relat Res 2009; 467 (09) 2297-2304
  • 2 Johanson PE, Antonsson M, Shareghi B, Kärrholm J. Early Subsidence Predicts Failure of a cemented femoral stem with minor design changes. Clin Orthop Relat Res 2016; 474 (10) 2221-2229
  • 3 Kitamura S, Hasegawa Y, Iwasada S, Yamauchi K, Kawamoto K, Kanamono T. , et al. Catastrophic failure of cementless total hip arthroplasty using a femoral component without surface coating. J Arthroplasty 1999; 14 (08) 918-924
  • 4 Macedo CAS. Desenvolvimento de haste femoral não cimentada nacional, validada por normas internacionais [tese]. Porto Alegre: Universidade Federal do Rio Grande do Sul; 2007
  • 5 Rozkydal Z, Janícek P, Havlícek V, Pazourek L. [Long-term results of use of the CLS stem in primary total hip arthroplasty]. Acta Chir Orthop Traumatol Cech 2009; 76 (04) 281-287
  • 6 Evola FR, Evola G, Graceffa A, Sessa A, Pavone V, Costarella L. , et al. Performance of the CLS Spotorno uncemented stem in the third decade after implantation. Bone Joint J 2014; 96-B (04) 455-461
  • 7 Yamasaki T, Yasunaga Y, Mori R, Hamanishi M, Shoji T, Ochi M. The Cementless Spotorno stem in THA: 10 year results. Hip Int 2014; 24 (01) 98-102
  • 8 Sidler-Maier CC, Waddell JP. Incidence and predisposing factors of periprosthetic proximal femoral fractures: a literature review. Int Orthop 2015; 39 (09) 1673-1682

Zoom Image
Fig. 1 Haste femoral não cimentada Logical – modelo inicial.[4]
Zoom Image
Fig. 2 Fotografias de uma haste Logical removida devido a infecção. Imagens demostrando nítido crescimento ósseo para a superfície porosa da haste.
Zoom Image
Fig. 1 Cementless femoral stem Logical – initial model.[4]
Zoom Image
Fig. 2 Photographs of a Logical stem removed due to infection. The images show clear bone growth at the porous surface of the stem.
Zoom Image
Fig. 3 Aspecto radiográfico da haste não cimentada Logical – artroplastia do quadril esquerdo realizada em 2012.
Zoom Image
Fig. 3 Radiographical aspect of the Logical cementless stem – left hip arthroplasty performed in 2012.
Zoom Image
Fig. 4 Sobrevida do implante LOGICAL CM dos pacientes operados entre janeiro de 2004 e dezembro de 2009. Um total de 95,1% dos implantes tiveram uma sobrevida média de 12,72 ± 0,09 anos (média ± desvio padrão), sendo 12,57–12,87 anos o intervalo de confiança.
Zoom Image
Fig. 5 Sobrevida do implante LOGICAL CM dos pacientes operados entre janeiro de 2004 e dezembro de 2009 avaliando diferenças entre os sexos. Não houve diferença na sobrevida média do implante comparando os sexos masculino e feminino. Foi utilizado teste de Log Ranl (Mantel-Cox) (p = 0,878). Sobrevida média de 12,74 ± 0,10 anos para o sexo feminino e de 12,73 ± 0,13 meses para o sexo masculino.
Zoom Image
Fig. 6 Risco cumulativo de falha do implante LOGICAL CM dos pacientes operados entre janeiro de 2004 e dezembro de 2009 ao longo de 12,5 anos foi de 10,7%.
Zoom Image
Fig. 7 Sobrevida do implante LOGICAL CM dos pacientes operados entre janeiro de 2004 e dezembro de 2009. Um total de 98,5% dos implantes tiveram uma sobrevida média de 7,89 ± 0,04 anos (média ± desvio padrão), sendo 7,81–7,98 anos o intervalo de confiança.
Zoom Image
Fig. 8 Sobrevida do implante LOGICAL CM dos pacientes operados entre janeiro de 2004 e dezembro de 2009 avaliando diferenças entre os sexos. Não houve diferença na sobrevida média do implante comparando os sexos masculino e feminino. Foi utilizado teste de Log Ranl (Mantel-Cox) (p = 0,287). Sobrevida média de 7,94 ± 0,04 anos para o sexo feminino e de 7,85 ± 0,06 anos para o sexo masculino.
Zoom Image
Fig. 9 O risco cumulativo de falha do implante LOGICAL CM dos pacientes operados entre janeiro de 2004 e dezembro de 2009 ao longo de 8 anos foi de 6,51%.
Zoom Image
Fig. 10 Tamanhos dos componentes femorais.
Zoom Image
Fig. 4 LOGICAL CM implant survival in patients operated from January 2004 to December 2009. Over 95% of the implants had a mean survival of 12.72 ± 0.09 years (mean ± standard deviation) with a confidence interval of 12.57–12.87 years.
Zoom Image
Fig. 5 LOGICAL CM implant survival in patients operated from January 2004 to December 2009 evaluating differences between genders. There was no difference in the mean implant survival comparing males and females. The Log Ranl test (Mantel-Cox) was used (p = 0.878). The mean survival was 12.74 ± 0.10 years for females and 12.73 ± 0.13 years for males.
Zoom Image
Fig. 6 The cumulative risk of failure of the LOGICAL CM implant in patients operated from January 2004 to December 2009 over 12.5 years was 10.7%.
Zoom Image
Fig. 7 LOGICAL CM implant survival in patients operated from January 2010 to December 2015. Over 98% of the implants had a mean survival of 7.89 ± 0.04 years (mean ± standard deviation), with a confidence interval of 7.81–7.98 years.
Zoom Image
Fig. 8 LOGICAL CM implant survival of patients operated from January 2010 to December 2015 evaluating differences between genders. There was no difference in the mean implant survival comparing males and females. The Log Ranl test (Mantel-Cox) (p = 0.287) was used. The mean survival was 7.94 ± 0.04 years for females and 7.85 ± 0.06 years for males.
Zoom Image
Fig. 9 The cumulative risk of failure of the LOGICAL CM implant in patients operated from January 2010 to December 2015 over 8 years was 6.51%.
Zoom Image
Fig. 10 Femoral components sizes.